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ABSTRACT
IN VITRO ASSESSMENT OF THE TOXICITY OF COCAINE 
AND ITS METABOLITES IN THE HUMAN UMBILICAL ARTERY
by
Tessa L. Long
An in vitro model was used to assess the effect o f cocaine and its metabolites on 
the umbilical artery. Objectives were to pharmacologically confirm the presence 
of adrenergic innervation using tyramine, evaluate the ability of cocaine, 
benzoylecgonine, norcocaine and cocaethylene to potentiate vasoconstriction by 
serotonin and norepinephrine, examine the ability o f ketanserin to block the 
enhanced vasoconstriction produced by cocaine, and determine displacement of 
3H-ketanserin by serotonin, norepinephrine, tyramine and mianserin.
The vasoconstrictive effect of tyramine (100 |iM) was enhanced in the presence of 
cocaine by 257%. Vasoconstrictive effects o f serotonin and norepinephrine were 
significantly enhanced by cocaine by 28%, and 64% respectively; producing 
significant increases in the cumulative response. Norcocaine significantly 
augmented the maximum response to norepinephrine by 54%. Benzoylecgonine 
significantly decreased the maximum response to serotonin by 36% as well as the 
cumulative response.
Ketanserin (0.03 jiM) completely attenuated the vasoconstricitive potentiation of 
serotonin and norepinephrine by cocaine; shifting the EC50 for serotonin to the 
right 10-fold in the presence of ketanserin and cocaine. Ketanserin shifted the 
EC 15 for norepinephrine with cocaine to the right 205-fold. Maximum response 
to norepinephrine with cocaine was depressed 54% by ketanserin.
Serotonin, tyramine, and mianserin were able to displace 3H-ketanserin (3 nM) 
from the membrane fraction of the human umbilical artery. This indicates 
serotonin2 receptor involvement in vasoconstrictive responses to serotonin and 
tyramine. Norepinephrine did not displace 3H-ketanserin in the membrane fraction 
of the umbilical artery.
iii
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These data suggest that enhanced vasoconstriction o f norepinephrine and serotonin 
by cocaine and potentiation of the maximum response to norepinephrine by 
norcocaine in the human umbilical artery may be important components of 
perinatal cocaine toxicity. Ketanserin was able to suppress the umbilical artery 
constriction produced by cocaine, demonstrating its antidotal potential. The 
potentiation o f the tyramine response by cocaine and the displacement o f 3H- 
ketanserin by tyramine indicate that tyramine may be producing its 
vasoconstrictive effect through serotonin2 receptors in the human umbilical artery.
iv
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CHAPTER 1
INTRODUCTION
Survey of Deleterious Perinatal Cocaine Effects 
Human epidemiological data has consistently implicated cocaine use during 
pregnancy with various perinatal and postnatal complications. Infants bom to 
cocaine abusing mothers suffer many complications including genito-urinary 
anomalies (Chasnoff et al. 1988), cerebral infarct (Chasnoff et al. 1986), and 
ischemic infarct of the bowel (Telsey et al. 1988) as well as various other 
anomalies. A study conducted by MacGregor et al. (1987) surveyed the outcome 
of 70 newborns, those infants exposed to cocaine in utero presented with 
significantly lower birth weights as well as increased incidence o f prematurity, 
preterm delivery, and small for gestational age newborns. Perinatal cocaine abuse 
often compromises the pregnancy itself with increased incidence of placental 
abruption (Acker et al. 1983; Chasnoff et al. 1985; Oro and Dixon 1987), stillbirths 
(Bingol et al. 1987), spontaneous abortion, and preterm labor (Chasnoff et al.
1985; Chasnoff et al. 1987; MacGregor et al. 1987; Collins et al. 1989). These 
effects seem to be predominantly related to the vasoconstrictive and hypertensive 
actions of cocaine (Plessinger and Woods 1991).
1
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2Animal models have provided useful information concerning cocaine 
mechanisms which contribute to deleterious perinatal and postnatal effects. 
Placental vasoconstriction as a consequence o f cocaine administration has been 
observed in a mouse model by Mahalik et al. (1984) and by Malek et al. (1995) in 
isolated term human placenta. Several studies have confirmed the ability o f  
cocaine to reduce uterine blood flow. Among the first to conduct such studies was 
Mahalik et al. (1984), who observed this decrease in blood flow in response to 
norepinephrine mediated vasoconstriction in the pregnant ewe. They 
demonstrated this concept experimentally by incorporating tropacocaine, an agent 
similar to cocaine which does not inhibit the reuptake of norepinephrine into the 
nerve terminal. In cocaine-exposed animals, there was a decrease in the amount of 
radio labeled sodium transferred to the embryos. However, in the tropacocaine- 
exposed animals the transfer of the isotope was not reduced significantly. In 
response to intravenous cocaine administered to the uterine vasculature o f the 
pregnant ewe (Woods et al. 1987; Moore et al. 1986), and to the pregnant 
nonhuman primate (Morgan et al. 1991), a dose-dependent reduction of uterine 
blood flow was observed. This results in increased blood pressure and restricts the 
delivery of essential nutrients and oxygen to the fetus.
Moreover, it has been established that cocaine readily crosses the placenta, 
producing increases in fetal heart rate and blood pressure in the pregnant ewe
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3(Woods et al. 1987). Numerous studies conducted in animal models indicate that 
cocaine and its metabolites are rapidly transferred across the placenta to the fetal 
compartment (Moore et al. 1986; Woods et al. 1989). Schenker et al. (1993) 
observed that cocaine and its metabolites are transferred across the isolated human 
placenta almost as rapidly as antipyrine, a substance which is used as a marker for 
placenta flow. These observations suggest that cocaine may exert its detrimental 
effects not only by producing fetal hypoxemia through reduction of blood flow to 
the uterine and placental vasculature, but also by crossing the placenta to have 
direct effects on the fetus.
Several of the perinatal and postnatal cocaine effects observed in animal 
models have been linked to similar effects observed in human epidemiological 
data. These effects are produced by vasoconstriction and include placental 
abruption, placental constriction, reduced uterine blood flow and decreased 
viability o f the fetus. Animal model correlations provide some insight concerning 
the perinatal toxic potential of cocaine, however, the full impact of continuous 
cocaine abuse throughout the pregnancy remains to be elucidated.
Survey of Cocaine Effect on the Human and Ovine Umbilical Artery
The umbilical vasculature is an important component of the maternal-fetal 
unit which has not been carefully assessed in terms o f its contribution to the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4vasoconstrictive effects associated with cocaine abuse during pregnancy. Dyer 
(1970) produced a dose-dependent potentiation of serotonin vasoconstriction by 
cocaine in isolated strip preparations o f ovine umbilical arteries, but saw no such 
potentiation of norepinephrine responses. In the isolated guinea pig umbilical 
artery, Nair and Dyer (1974) found that cocaine potentiated the contractions 
produced by serotonin and norepinephrine, shifting the dose-response curves to the 
left three-fold. Hoskins et al. (1991) performed umbilical artery Doppler flow 
velocimetry studies on 314 women who had a history of cocaine abuse, and 
placental abruption or preterm labor and compared these women with controls 
presenting with placental abruption or preterm labor but did not use cocaine. They 
reported cocaine abuse associated with placental abruption, preterm birth, and low 
birth weight was correlated with increased systolic/diastolic ratios in human 
umbilical artery blood flow in some women. Recently, Zhang and Hu (1998) 
demonstrated that cocaine potentiates isolated ovine umbilical artery contractions 
produced by serotonin in the endothelium-intact preparation. These studies 
provide evidence that cocaine may directly potentiate constriction o f the umbilical 
artery.
Bodelsson and Stjemquist (1995) did not observe a potentiation of 
norepinephrine by cocaine in the isolated human umbilical artery. This suggests 
that serotonin may be more important to umbilical artery vasoconstriction as
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5a possible contributing factor in the morbidity and mortality associated with 
cocaine exposure to the developing fetus.
Pharmacological Mechanism of Cocaine 
The adverse perinatal and neonatal outcomes associated with cocaine abuse 
during pregnancy have generally been attributed to the vasoconstrictive effects of 
cocaine and its metabolites. This vascular effect is thought to be related to the 
ability of cocaine and its metabolites to block the reuptake of norepinephrine at the 
presynaptic nerve terminal, inhibiting the primary means of inactivation for this 
neurotransmitter (Furchgott et al. 1963).
Several very elegant studies have contributed to what is now known about 
the pharmacological actions of cocaine. A study conducted by Lockett and Eakins 
(1960) revealed that cocaine was able to abolish the pressor response to tyramine 
in cats. Since tyramine is an indirect acting sympathomimetic which produces its 
effects by displacing norepinephrine from presynaptic nerve terminals, the results 
of this study indicate that cocaine exerts its effect by altering the transport of 
catecholamines into the nerve terminal. This mechanism was first described by 
Kirpekar et al. (1962), who proposed that cocaine blocks a specific "transfer site". 
Furchgott et al. (1963), Trendelenburg (1965), Johnson and Kahn (1966), and 
Barnett et al. (1968) have provided definitive evidence that cocaine blocks the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure I. Diagrammatic representation of the pharmacological mechanism of cocaine.
synaptic reuptake of catecholamines, increasing norepinephrine levels and post- 
synaptic stimulation o f adrenergic receptors (Bayorh et al. 1983) (Figure 1).
Systemic pressor effects of cocaine administration are produced by 
increased plasma levels o f norepinephrine which increase systemic vascular 
resistance. Thus, many o f the toxic effects associated with perinatal cocaine abuse 
may be due to its hemodynamic alterations. If the response of the umbilical 
vasculature is similar to that o f other tissues, vasoconstriction of this tissue could 
contribute to the reduced perfusion o f the developing fetus resulting in many o f the 
previously described perinatal complications.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7Survey of the Vascular Effects of Cocaine Metabolites 
Cocaine is extensively metabolized in the plasma and liver, its metabolites 
are cleared from the plasma more slowly than cocaine itself (Jatlow 1987). Several 
o f the resulting metabolites exhibit pharmacological activity similar to that of 
cocaine. Benzoylecgonine is the major metabolite (80%) of cocaine formed after 
hydrolysis by nonspecific plasma and liver esterases. Benzoylecgonine is reported 
to possess pharmacological activity to produce vasoconstriction o f cat cerebral 
arteries (Madden and Powers 1990). Cocaethylene (Jatlow et al. 1991) is a toxic 
metabolite of cocaine formed by the liver when cocaine and ethanol are used 
concomitantly by benzoylecgonine carboxylesterase (Boyer and Petersen 1991), 
the amount of cocaethylene formation is dependent on plasma concentration of 
ethanol. The presence of ethanol shifts metabolism of cocaine from 
benzoylecgonine to cocaethylene and increases the formation of norcocaine (Farre 
et al. 1993). Cocaethylene is purported to be more cardiotoxic than cocaine 
(Randall 1992) and exhibits a lower LD50 in mice (Hearn et al. 1991). Norcocaine 
is formed by N-demethylase in human liver and accounts for 20% of cocaine 
metabolism (Stuart et al. 1979). Norcocaine is more efficacious than cocaine itself 
at inhibiting synaptic reuptake of norepinephrine (Hawks et al. 1975). In one 
experiment involving porcine fetal cerebral arteries, cocaethylene was able to 
produce vasoconstriction in these vessels more efficaciously than cocaine. In the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8same study, norcocaine was shown to constrict these vessels as efficaciously as 
cocaine itself (Kurth et al. 1993). Similar effects were described in fetal lambs, 
Covert et al. (1994) reported increased cerebral vascular resistance in response to 
cocaethylene and benzoylecgonine administration.
Dining pregnancy, the toxicity of cocaine and its metabolites is greater due 
to decreased activity of cytochrome P450 enzymes and increased plasma levels of 
progesterone (Neale and Parks 1973). Progesterone increases enzymatic 
demethylations thereby increasing plasma concentrations of longer-lived toxic 
cocaine metabolites and by increasing vascular reactivity to alpha-adrenergic 
receptor agonists. Pregnancy itself enhances cocaine sensitivity by increasing the 
formation o f norcocaine and cocaethylene while decreasing norcocaine 
metabolism. In one study, the cardiovascular toxicity to cocaine was shown to be 
increased in the presence of progesterone in nonpregnant ewes (Plessinger and 
Woods et al. 1990).
Question of Innervation in the Human Umbilical Cord 
The subject of innervation in the umbilical vasculature has been a topic of 
controversy for several decades. Even as recently as 1990 the conflict continued; 
it was demonstrated that adrenergic and cholinergic nerve fibers are present in 
umbilical arteries at the fetal end o f the human umbilical cord using histochemical
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9techniques (Kawano and Mori 1990). In the same year another study reported no 
evidence o f innervation using immunohistological and histochemical techniques 
(Fox and Khong 1990).
Functional in vitro studies have provided some information that supports 
the existence innervation o f human umbilical arteries. Gulati and Kelkar (1970) 
found that cocaine potentiates the responses o f norepinephrine and serotonin in a 
human whole cord perfusion study. They also found that tyramine produced 
vasoconstriction of the artery and this response was potentiated by cocaine. These 
findings suggest that the human umbilical cord is innervated and that cocaine and 
its metabolites potentiate responses to serotonin and norepinephrine thereby 
contributing to toxic vasoconstrictive situations produced with perinatal cocaine 
abuse.
Question of Receptor Types Present in Human Umbilical Arteries 
Norepinephrine produces contractions o f less than half the KC1 maximum 
in isolated umbilical arteries even at high concentrations (Bodelsson and 
Stjemquist 1995). This is a very unusual response for arterial tissue which is 
normally characterized as primarily alpha-adrenoceptor mediated. Bodelsson and 
Stjemquist (1995) were able to produce contractions of isolated human umbilical 
artery rings with oxymetazoline, an alpha2 agonist, however the maximum
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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response was five times higher than that o f norepinephrine itself suggesting that 
oxymetazoline produced its effects through another receptor. The authors 
concluded that oxymetazoline was probably acting through serotonin receptors 
since methysergide, a nonspecific serotonin antagonist, produced a parallel shift in 
the concentration-effect curve for oxymetazoline. In the same study, the authors 
noted that prazosin (alpha, antagonist) produced concentration-dependent 
reductions in the concentration-effect curves to norepinephrine, but not a parallel 
shift o f the response. The authors concluded that norepinephrine produced its 
effects through both alpha, and alpha2 receptors. Adding to the confusion, Tuncer 
et al. (1985) were not able to produce contractions of this tissue at all with 
clonidine, an alpha, agonist. These observations suggest that norepinephrine may 
be producing its effects through another receptor type, possibly serotonin 
receptors.
Serotonin is a very potent vasoconstrictor of human umbilical arteries 
(Gokhale et al. 1966; Altura et al. 1972; Tuncer et al. 1985; McGrath et al. 1988; 
Yoshikwa and Chiba 1991) and this response is antagonized by the serotonin2 
receptor antagonists ketanserin and mianserin (Tuncer et al. 1985). The pA2 
values (slope of the regression of KD values obtained for an agonist over several 
concentrations o f antagonist) reported in Tuncer’s study in the human umbilical 
artery for ketanserin and mianserin were 7.89 and 8.06. These values were
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
significantly lower than those reported for other tissues; including rat jugular vein 
(Cohen et al. 1983) and rat uterus (Ichida et al. 1983), where observed mianserin 
pA2 values were 9.30 and 9.70, and in the same tissues as well as calf coronary 
arteries (Kaumann 1983) and rat tail arteries (Hicks and Langer 1983) ketanserin 
pA2 values ranged from 9.10-9.80. Based on these numbers Tuncer et al. (1985) 
concluded that serotonin induced contractions in the isolated human umbilical 
artery were mediated by neither serotonin, nor serotonin2 receptors.
These contributions to the literature concerning the receptor types 
responsible for norepinephrine and serotonin mediated contractions of isolated 
human umbilical arteries leave many unanswered questions about the serotonin 
and alpha, adrenoceptor population present in this tissue. This information is vital 
to the understanding of how cocaine might be exerting its effects and what 
compounds might be useful in antagonizing cocaine potentiation of norepinephrine 
and serotonin vasoconstriction.
Role o f Ketanserin in the Treatment of Hypertension
Serotonin seems to play an important role in the sequelae of preeclampsia- 
eclampsia. Several studies have noted the benefit of ketanserin therapy in the 
treatment o f this perinatal complication (Ghisoni 1990; Rossouw et al. 1995; Steyn 
and Odendaal 1997). Rossouw et al. (1995) found ketanserin to be a safer
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alternative to hydralazine therapy in late term hypertension and Steyn and 
Odendaal (1997) found ketanserin to be a beneficial addition to low dose aspirin 
therapy among women with mild to moderate midtrimester hypertension. 
Ketanserin has also been found to be useful in other types of hypertensive 
situations (Van Neuten et al.1981; DeCree et al. 1981; Symoens and Janssen 
1986). Tuncer et al. (1985) did notice that ketanserin produced effects on isolated 
human umbilical artery strips, significantly shifting concentration-effect curves to 
serotonin. This information opens the possibility of a role for ketanserin in 
perinatal hypertensive situations produced by cocaine abuse.
Statement of the Problem 
Human epidemiological data, whole animal studies, and isolated tissue 
studies have confirmed that cocaine produces vasoconstrictive situations which 
contribute to the well documented deleterious consequences o f perinatal cocaine 
abuse. The contribution o f placental and uterine vasoconstriction has been 
established in animal models and in isolated perfused placentas. The constriction 
o f umbilical vessels in this situation has not been studied as carefully. Research to 
date indicates that cocaine may produce potentiation of serotonin and/or 
norepinephrine mediated vasoconstriction in the human umbilical artery, further
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exacerbating the reduced perfusion o f the fetus produced by the constriction of the 
uterine artery and the placental vasculature.
Requisite to a situation whereby cocaine produces a vasoconstrictive or 
hypertensive situation in the umbilical artery via its conventionally described 
mechanism is the presence o f nerve terminals in the smooth muscle o f the 
vasculature. There is histological (Kawano and Mori 1990) and functional (Gulati 
and Kelkar 1970) data to indicate that human umbilical arteries are innervated. 
However, this tissue is usually described as non-innervated due to previous 
histological studies which were unable to detect nerve endings in the human 
umbilical cord. Central to understanding the mechanisms by which cocaine might 
produce vasoconstriction in this tissue is determination of innervation.
The ability o f cocaine to potentiate norepinephrine induced 
vasoconstriction in the human umbilical artery is disputed by Bodelsson and 
Stjemquist (1995) and supported by Gulati and Kelkar (1970). Gulati and Kelkar 
(1970) found that cocaine also potentiated the vascular response o f serotonin in the 
whole perfused human umbilical cord. Zhang and Hu (1998) noted the same effect 
in isolated ovine umbilical artery rings. This effect as well as the impact of 
pharmacologically active circulating metabolites o f cocaine requires further 
elucidation.
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Several experiments have failed to reveal definitive information about the 
receptor types responsible for the vasoactive effects o f norepinephrine and 
serotonin in the umbilical artery. Bodelsson and Stjemquist (1995) concluded that 
alpha, and alpha2 adrenoceptors are responsible for norepinephrine induced 
contractions of isolated human umbilical artery rings even though they were 
unable to produce parallel shifts in concentration-effect curves with alpha 
antagonists and Tuncer et al. (1985) failed to produce contractions o f human 
umbilical arterial strips with alpha2 agonist clonidine. Tuncer et al. (1985) were 
also unable to describe the receptor types responsible for serotonin induced 
contractions, though ketanserin and mianserin did produce parallel shifts in 
concentration-effect curves. Receptor-binding studies would help to further 
establish receptor types present in this tissue.
Ketanserin may provide a useful antidote for the acute toxicity o f perinatal 
cocaine abuse. This agent has proven useful in clinical trials for the treatment of 
pregnancy-induced hypertension, preeclampsia-eclampsia (Rossouw et al. 1995). 
The potency of serotonin in the umbilical artery indicates that potentiation of 
serotonin responses could be very devastating to the developing fetus exposed to 
cocaine. Functional studies in the human umbilical artery by Tuncer et al. (1985) 
indicate that ketanserin may be useful in the treatment of a hypertensive situation 
where fetal hypoxia and placental abruption are impending.
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Aims of the Study
The present study was designed to assess the toxicity of cocaine in vitro in 
the isolated human umbilical artery. Experiments were designed to provide 
information about several functional aspects of the umbilical artery itself and the 
impact of cocaine and its pharmacologically active metabolites in this system.
The experimental goals are as follows:
1. To determine the effect of tyramine on the isolated human umbilical artery. 
These experiments would provide information about the extent of 
innervation in this tissue.
2. To determine the ability of cocaine and its pharmacologically active 
metabolites, cocaethylene, norcocaine, and benzoylecgonine, to potentiate 
the vasoconstrictive responses to norepinephrine and serotonin in isolated 
human umbilical arteries.
3. To determine the ability of serotonin2 antagonist ketanserin to attenuate the 
augmentation o f serotonin and norepinephrine effects by cocaine in 
umbilical arteries.
4. To determine the effect of methoxamine, an alpha, agonist, on umbilical 
arteries. This will provide information concerning the receptor types 
involved in the response to norepinephrine.
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5. To determine if  norepinephrine, serotonin, tyramine, and mianserin interact 
with the serotonin2 receptors by displacement of 3H-ketanserin in isolated 
membrane fractions of umbilical arteries.
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CHAPTER 2
MATERIALS AND METHODS 
Subjects
The protocol for this study was approved by the East Tennessee State 
University and the Johnson City Medical Center Institutional Review Boards. 
Pregnant women under the care o f University Physicians Practice Group - 
Obstetrics and Gynecology at Johnson City Medical Center were asked to 
participate in this study. All subjects were informed of their rights as a human 
subject and signed an informed consent (see Appendix A and B for informed 
consent and IRB approved protocol). Women with a history o f perinatal drug 
abuse, hypertension, or pregnancy induced hypertension were excluded from the 
study. Umbilical cord sections were taken from the fetal end o f the umbilical cord, 
within 15 cm o f the fetus.
Contractile Studies of the Human Umbilical Artery
Tissue Preparation and Equilibration
Umbilical cords were collected from term vaginal or cesarean deliveries and 
immediately placed in oxygenated, modified Krebs-Henseleit buffer (see 
Appendix C for preparation scheme) of the following composition (mM): NaCl
17
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(112.94), KC1 (4.75), CaCl2 (2.52), MgS04 (1.19), Dextrose (5.55), KH2P04 
(1.18), and NaHC03 (25.00), and stored until dissection at room temperature. 
Tissues were prepared for experimentation within 2 hours of collection. Sections 
of artery were dissected from the cord and carefully cleared of Wharton’s jelly 
(under buffer) using fine forceps and a FISHER Stereoscope. Sections were cut 
with fine surgical scissors while still under buffer to make 3mm rings of arteries. 
The rings were placed in individual jacketed organ baths containing modified 
Krebs-Henseleit buffer. The baths and the buffer were maintained at 37° C 
throughout the experiments and the buffer was continuously aerated with a 
mixture of 95%02/5% C02. Buffer in the organ baths was replaced every 20-30 
min throughout the experiments with pre-warmed modified Krebs-Henseleit 
buffer.
Measurement of the Contractile Response
Umbilical artery rings were suspended horizontally in 8.2 ml organ baths by 
two hooks which were placed through the lumen o f the vessel. The upper hook 
was attached to Grass model FT03C force displacement transducers (Quincy, MA) 
via surgical suture, and the bottom support was stabilized outside the bath with a 
clamp. Isometric contractile responses were recorded by a Grass Model 7D 
polygraph (Quincy, MA). Tissues were allowed to equilibrate for 90-120 minutes
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under 2gm tension (optimal resting tension as determined empirically) then 
contracted every 30 min with 65mM KC1 (replacing Na+) in modified Krebs- 
Henseleit buffer (see Appendix D for preparation scheme) until contractions were 
stable to determine tissue viability and maximum standard response o f each tissue. 
Experiments were performed to determine the length o f time tissues would 
maintain stable contractions with 65 mM KC1. Receptor agonists were dissolved 
in water and administered in 8.2 pi volumes with Eppendorf digital pipettes to 
yield the appropriate molar concentrations. Cumulative concentration-effect 
curves (van Rossum 1963) to agonists were constructed by the addition o f log or 
0.5 log concentration increments to the bath to yield final concentrations as 
indicated. A period of at least 2.5 min for measurement of maximum response was 
allowed after addition of each concentration. Tissues were washed at least twice 
after a concentration-effect curve and allowed to return to basal tension before the 
next concentration-effect curve was begun. Several concentration-effect curves 
were constructed for each agonist over a period of several hours to determine 
increases and decreases in sensitivity to each agonist.
Assessment of Innervation
The innervation of the human umbilical artery was assessed using tyramine, 
an indirect acting sympathomimetic which enters adrenergic nerve terminals and
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elicits a contractile response by causing the release of endogenous norepinephrine. 
Tissues were exposed to 10 pM and 100 (iM concentrations o f tyramine, then 
washed with fresh buffer and allowed to relax. Once the tissues had relaxed to 
baseline tension the rings were exposed to buffer containing 10 pM cocaine for 30 
minutes then reexposed to each concentration o f tyramine. A 10 pM concentratio 
of cocaine was used to assure complete blockade of the uptake-1 site.
Agonist Responses in the Presence and Absence of Cocaine
In order to assess the ability of cocaine to enhance responses to endogenous 
neurotransmitters concentration-effect curves were constructed for norepinephrine, 
and serotonin in the presence or absence o f cocaine. Tissues were exposed to 
cumulative concentrations o f either serotonin or norepinephrine (0.01 - 10 pM). 
Tissue rings were then rinsed with fresh buffer and allowed to relax back to 
baseline tension. Cocaine (10 pM) was added to the baths and after an 
equilibration of 30 min, the concentration-effect curves for serotonin or 
norepinephrine were reconstructed in the presence of cocaine. The presence or 
absence o f cocaine was randomized and each tissue served as its own control.
Effect o f Benzolecgonine. Norcocaine. and Cocaethylene on Agonist Responses 
The ability o f pharmacologically active metabolites of cocaine to potentiate 
responses to serotonin and norepinephrine (0.01 - 10 pM) was determined and
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compared to cocaine. Concentration-effect curves for norepinephrine or serotonin 
were constructed in log increments as described and then tissues were washed and 
allowed to relax to basal tension. Tissues were incubated for at least 30 min with 
buffer containing 10 pM concentrations of either benzoylecgonine, norcocaine, or 
cocaethylene and concentration-effect curves to either serotonin or norepinephrine 
were reconstructed in the presence of one of these metabolites. The addition of 
metabolites was randomized to the control and each tissue served as its own 
control. Metabolite concentrations of 10 pM were used to assure complete 
blockade of the uptake-1 site.
Determination of Alpha, Receptor Presence
In order to determine alpha, receptor presence in human umbilical arteries 
additions of methoxamine, a potent alpha, receptor agonist, were made. Additions 
were made in log increments over the concentration range 0 .01-10 pM. These 
additions were also made in the presence of 10 pM cocaine.
Ability of Ketanserin to Attenuate Effects of Cocaine
In order to assess the ability of ketanserin to attenuate the enhanced effects 
of cocaine on human umbilical arteries, rings were exposed to either 
norepinephrine or serotonin alone, with cocaine, or with ketanserin and cocaine. 
Rings were exposed to cumulative concentrations (0.01 -10  pM in 0.5 log
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increments) of either norepinephrine or serotonin. After tension equilibrated back 
to baseline the tissues were incubated for 30 min with cocaine (IOjiM) and the 
concentration-effect curves to norepinephrine and serotonin were reconstructed in 
the presence or absence of buffer containing ketanserin (0.03 pM), this 
concentration should have produced a 30-fold shift in the concentration-effect 
curve for serotonin. The combinations of norepinephrine or serotonin alone, with 
cocaine, or with cocaine and ketanserin were randomized.
Membrane Binding Studies
Tissue Preparation and Storage
Umbilical arteries for these studies were matched to umbilical artery 
samples used in the ketanserin isolated tissue contractile studies. At the time of 
the isolated tissue studies, an additional sample of each artery, 2 cm in length, was 
cleaned as previously described and immediately frozen on dry ice. Tissue 
samples were stored at -80°C until processed for membrane binding studies.
Membrane Preparation
Arterial sections were thawed at room temperature and wet weights were 
determined using a digital balance. Tissue samples were cut into small ( 2 x 2  mm) 
pieces with surgical scissors under 2ml of ice-cold 250 mM sucrose solution in a
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small dish, then transferred to a 25ml polystyrene tube along with an additional 5 
ml o f sucrose solution for a total o f 7 ml and homogenized with a Tekmar 
Tissuemizer (Cincinnati, OH) at high speed for 20 sec. This homogenate was 
transferred to a cold 7 ml ground glass tissue grinder and manually homogenized, 
then transferred back to the polystyrene tube for low speed centrifugation with a 
Beckman Model J-6 centrifuge (Beckman Instruments, Irvine, CA) at 1086 g  for 
10 min at 0°C. The supernatant was diluted 10-fold with Tris buffer (50 mM, pH 
7.7), and centrifuged with a Beckman Model L5-65B utracentrifuge (Beckman 
Instruments, Irvine, CA) at 50,000 g for 15 min at 0°C. The supernatant was 
discarded and the pellet was resuspended in 12.5 ml of fresh Tris buffer. The 
membrane suspension was frozen at -80°C until the binding experiments were 
conducted (see Figure 2 on the following page for a diagram of the preparation 
scheme).
Binding Assay Procedure
Protein Assay. Aliquots (100 pi) of the membrane preparation samples in 
Tris buffer were assayed for protein content with bovine serum albumin as the 
protein standard using Bradford (1976) microtiter plate protocol, see Appendix E 
for protocol.
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Competitive Binding Assay. The binding characteristics o f unlabeled ketanserin, 
mianserin, serotonin, or tyramine (0.001 pM - 100 pM), and norepinephrine (10 
pM) were determined by competitive binding o f these agents with 3H-ketanserin. 
The assay was performed using the Millipore Multi-Screen Filtration System, this 
96-well plate contained individual 1.2 pm glass fiber type C filters. The assay 
was carried out in these wells on ice with 0.7 - 1.0 pg protein per 100 p i , 3 nM of 
3H-ketanserin (50 pi), and 100 pi of competitive drug for a total volume of 250 pi 
in each. Competitive binding assays for serotonin, norepinephrine, and tyramine 
also included 10 pM pargyline and 0.1% ascorbic acid to prevent their metabolism 
during incubation. All buffers and drug dilutions were kept ice-cold and additions 
were made on ice. The plates were incubated in a Reciprocal Shaking Bath Model 
25 (Precision Scientific, Chicago, IL) for 20 min at 37° C, pH 7.4 with agitation 
(60 cycles per min).
At the end of the incubation period, the plates were quickly removed from 
the incubator and placed in the Millipore vacuum manifold. Contents of the wells 
were vacuum filtered and washed once with 250 pi Tris buffer (room temperature). 
Each filter was removed from the plate and placed in a 7 ml scintillation vial with 
4 ml o f CytoScint (Fisher Biotech, Pittsburgh, PA) scintillation cocktail. Vials 
were counted for 10 min each in a Wallac model 1409 liquid scintillation counter 
(Gaithersburg, MD).
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Calculations and Statistics
Contractile Studies
Data are represented by the mean ±  standard error of the mean (S.E.M.) 
responses expressed as a percent o f the paired, KC1 maximum, for 5 subjects.
Data representation by this method decreased the variation between subjects and 
allowed for more rigorous comparisons. Concentration-effect curves were 
compared by several different methods. Comparisons were always made for each 
dose of agonist in the presence and absence of cocaine using paired Student’s t- 
tests. Cumulative response was further analyzed by calculation o f the area under 
the concentration-effect curve for each tissue in the presence and absence of 
cocaine using the trapezoidal rule (Wagner 1979). The area under the 
concentration-effect curve was defined as:
I 1/2(0 , + c ^ - r o ,
where C = molar concentration o f drug and R = % KC1 Max. ECS0 and ECl5 
values, the mean effective concentrations to produce either 50 or 15% of the 
maximum response to KC1, were calculated from log interpolation o f each 
concentration-effect curve. Dissociation constants (KB) for norepinephrine and 
serotonin were calculated using the equation from Kenakin et al. (1992), 
log IDose Ratio-1]  = log [Antagonist] - log KB,
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where the dose ratio is the ECS0 after antagonist addition /  ECS0 before antagonist 
addition and [Antagonist] is the concentration of ketanserin (0.03 (iM).
Levels o f p<0.05 were accepted as statistically significant differences 
between groups compared. Statistical comparisons were made on a GATEWAY 
2000 Personal Computer P5-166 XL and PROSTATstatistics package version 1.50 
and PSI-PLOT graphics package version 5.0, (Poly Software International, Salt 
Lake City, UT). Graphs were created using Graphpad PRISM version 2.01 
graphics package, (Graphpad Software, Inc., San Diego, CA).
3H-Ketanserin Binding Studies
Data obtained from the radioligand binding assays were converted from 
disintegrations per minute to picomoles of binding per milligram of protein using 
the Graphpad PRISM graphics package on a personal computer as previously 
described. The saturation binding curve for 3H-ketanserin was determined from 
the unlabeled ketanserin displacement curve. These values were then used to 
determine the binding maximum (Bmax) and dissociation constant (IQ) of 3H- 
ketanserin in the protein samples obtained from human umbilical arteries matched 
to ketanserin isolated tissue studies. Using Graphpad PRISM nonlinear regression 
analysis, the data were fit to the equation:
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Z? _ [Ligand!
Total Binding = ___________________ +  N [Ligand],
Kd+[Ligand]
where N * [Ligand] represents the nonspecific binding of the ligand. The Bmax 
represents the maximum number of specific binding sites in pmoles per mg protein 
and K<j represents the dissociation constant in nM of 3H-ketanserin for the binding 
site.
The data from the competitive binding studies were transformed to percent 
o f control binding for each of the displacing ligands. These values were then fit to 
a one or two site binding equation based on the calculated best fit using the 
Graphpad PRISM curve fitting program and the sequential F-test.
One site competition equation:
y = bottom + (top-bottom) / (1 + 10 A (x-log EC50))
Two site competition equation:
y = (bottom+top) * fraction 1/ (1 + 10 A (x-log EC50_1)) +
(bottom+top) * (1-fraction 1)/ (1 + 10 A (x-log EC50_2))
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Contractile Studies
(-)-Norepinephrine bitartrate, tyramine hydrochloride, 5-hydroxytryptamine 
hydrochloride, methoxamine hydrochloride, and dopamine hydrochloride, were 
purchased from Sigma Chemical Co., (St. Louis, MO). Norcocaine hydrochloride, 
cocaethylene hydrochloride, benzyolecgonine, cocaine hydrochloride, and 
ketanserin tartrate were purchased from Research Biochemicals International, 
(Natick, MA). All drugs were dissolved and diluted with ultra pure deionized 
distilled water (18 mOhm). Chemicals for modified Krebs-Henseleit buffer were 
purchased from Fisher Scientific (Pittsburgh, PA).
Binding Studies
Ketanserin hydrochloride, [ethylene-3H]-(R41 468), specific activity range 
60-90 Ci/mmol, > 97% radiochemical purity was obtained from New England 
Nuclear Life Science Products, Inc. (Boston, MA). Unlabeled competitive binding 
agents norepinephrine bitartrate, 5-hydroxytryptamine hydrochloride, and tyramine 
were purchased from Sigma Chemical Co. (St. Louis, MO) and dissolved and 
diluted in Tris buffer, pH 7.7. Ketanserin tartrate, and mianserin hydrochloride 
were purchased from Research Biochemicals International, (Natick, MA), 
dissolved in 0.1 N HC1 and diluted with Tris buffer. L-ascorbic acid and
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biological grade tris, and CYTOSCINT scintillation cocktail was obtained from 
Fisher Biotech, (Fair Lawn, NJ). Pargyline hydrochloride was purchased from 
Regis Chemical Co.
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CHAPTER 3
RESULTS
Contractile Studies in the Human Umbilical Artery
Normal Contractile Function
The exposure o f  umbilical artery rings to 65 mM KC1 produced a rapid 
increase in contractile force that reached a maximum within 30-60 seconds and 
was sustained at a steady tonic phase for 2-3 min (Figure 3). Responses to KC1 
were stable over the course o f the experimental time frame of 5-6 hours. Tyramine 
produced a similar response also shown in Figure 3, contractions to tyramine were 
also stable over a 2-3 hour period.
KCI TYRAMINE
TYRAMINE1 gm
S min
Figure 3. Typical isometric responses to 65mM KCI and tyramine.
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Isolated umbilical artery rings were used to produce concentration-effect 
curves for norepinephrine and serotonin over the concentration range 0.01 - 10 
pM, these concentration-effect curves were repeatable and remained stable for up 
to 5 hours.
Assessment of Innervation
In order to assess the presence o f innervation in the isolated umbilical artery 
tyramine was added to the preparation in 10 and 100 pM concentrations as 
previously described in the Materials and Methods section. Tissues were also 
exposed to tyramine in the presence o f 10 pM cocaine. Tyramine (10 pM) 
produced a slight vasoconstrictive response. Addition of cocaine (lOpM) did not 
significantly potentiate this response (Figure 4). The mean vasoconstrictive 
response to tyramine (100 pM) was significantly increased by 257% (p<0.05), in 
the presence of cocaine (lOpM) in comparison to tyramine alone at 100 pM 
(Figure 4).
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Figure 4. Effect of cocaine (10 pM) on the vasoconstrictive response to 
tyramine. Data are presented as mean ± S.E.M. for paired tissue comparisons, 
n=6,* p< 0.05.
Agonist Responses in the Presence o f Cocaine
Effect of Cocaine on Serotonin Responses. The dose-response curves for 
serotonin in the presence and absence of cocaine (lOpM) are presented in Figure 5. 
Cocaine produced a potentiation of the vasoconstrictive response to serotonin. In 
the presence of cocaine, the mean vasoconstrictive effect o f  serotonin from 0.1 pM 
to 10 pM was potentiated by 28% (p<0.05). In the presence o f cocaine, the tissue 
was more sensitive to serotonin. The area under the concentration-effect curve for 
serotonin in the presence of cocaine was significantly greater (p<0.05) than the 
area for serotonin alone (Table 1).
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Figure 5. Effect of cocaine (10 pM) on the vasoconstrictive response to 
serotonin. Data are presented as the mean ± S.E.M of paired tissue 
comparisons, n=6, * p<0.05.
TABLE 1.
Area under the cumulative concentration-effect 
curve* for serotonin and norepinephrine in the presence and absence of cocaine.
Neurotransmitter Neurotransmitter Alone Neurotransmitter with Cocaine
Norepinephrine 176.19 614.87*
(51.30) (203.49)
Serotonin 1071.65 1355.50*
(42.58) (111.82)
Data is the mean (S.E.M.) of 6 paired observations.
* indicates statistical significance (p<0.05).
* Area under the cumulative concentration effect curve is defined as
E 1/2(C, -K^O^R-i) where C = concentration of neurotransmitter and 
R = %contraction (KC1 max)/ pM concentration.
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Effect of Cocaine on Norepinephrine Responses. The concentration-effect 
curves produced by norepinephrine in this model were reproducible and the 
contractile response was induced in a dose-dependent manner. The concentration- 
effect curves for norepinephrine in the presence and absence o f cocaine (10|iM) 
are presented in Figure 6 . Cocaine potentiated the sensitivity to norepinephrine by 
about 25% at lower doses and by 64% at the maximum response to norepinephrine 
(10 pM) significantly, (p<0.05). The area under the concentration-effect curve for 
norepinephrine in the presence of cocaine was significantly greater than the area 
for norepinephrine alone (p<0.05), (Table 1). Cocaine produced a 60-fold, 
leftward shift in the concentration-effect curve. This indicates greater sensitivity 
of the umbilical artery to norepinephrine in the presence of cocaine.
O
<
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•  NOREPINEPHRINE
100
O  NOREPINEPHRINE with COCAINE
X
i  7 5
£  5 0
[NOREPINEPHRINE] (M)
Figure 6. Effect of cocaine (lOpM) on the vasoconstricitve response to 
norepinephrine. Data are presented as the mean ± S.E.M. of paired tissue 
comparisons, n=6, *p< 0.05.
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Agonist Responses in the Presence o f Benzovlecgonine
Effect of Benzoylecgonine on Serotonin Responses. The concentration- 
effect curves for serotonin alone and in the presence of benzoylecgonine are 
presented in Figure 7. Benzoylecgonine produced a decrease in the contractile 
response of the umbilical artery to serotonin, this effect was significant at 1 and 
10 pM where the responses were reduced by 36 and 30% respectively. The shift 
o f the concentration-effect curve to the right indicates a decrease in sensitivity to 
serotonin in the presence of benzoylecgonine. The area under the cumulative- 
concentration effect curve values for serotonin in the presence of benzoylecgonine 
were significantly less than for serotonin alone (Table 2).
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Figure 7. Effect of benzoylecgonine (10 |iM) on the vasoconstrictive reponse to 
serotonin. Data are presented as the mean ± S.E.M. of paired tissue responses, 
n=4, * p<0.05.
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TABLE 2.
Area under the cumulative concentration-effect curve+for serotonin and 
norepinephrine in the presence and absence of benzoylecgonine
Neurotransmitter Neurotransmitter alone Neurotransmitter with 
benzoylecgoninne
Norepinephrine 404.25 452.25
(162.13) (196.67)
Serotonin 1057.5 714.0*
(20.3) (124.5)
Data is the mean (S.E.M.) of 4 paired observations
* indicates statistical significance (p<0.05).
* Area under the cumulative concentration effect curve is defined as 
S 1/2(C, +C2)(R2 -R,) where C = concentration of neurotransmitter 
R =% contraction (KC1 max)/ pM concentration.
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Effect of Benzoylecgonine on Norepinephrine Responses. The 
concentration-effect curves for norepinephrine in the presence and absence of 
benzoylecgonine are presented in Figure 8. Benzoylecgonine produced no 
significant differences on the responses o f the isolated umbilical artery to 
norepinephrine. Benzolyecgonine did shift the EC 15 for norepinephrine to the 
right 4.5 fold, indicating decreased sensitivity of the tissue to norepinephrine in the 
presence of benzoylecgonine.
Figure 8. Effect of benzoylecgonine (10 pM) on the vasoconstrictive response to 
norepinephrine. Data are presented as paired tissue comparisons, mean ± S.E.M.,
8 5 . 
7 5 . 
O  6 5 .
•  NOREPINEPHRINE
O NOREPINEPHRINE WITH 
BENZOYLECGONINE
[NOREPINEPHRINE] (M)
n=4.
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Agonist Responses in the Presence o f Norcocaine
Effect of Norcocaine on Serotonin Responses. Concentration-effect curves 
for serotonin in the presence and absence of norcocaine (10 pM) are presented in 
Figure 9. Serotonin responses in the presence of norcocaine were not significantly 
different from control responses. Norcocaine did produce a slight leftward shift in 
the concentration-effect curve for serotonin and a slight potentiation of the 
maximum response (22%).
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Figure 9. Effect of norcocaine (lOpM) on the vasoconstrictive response to 
serotonin. Data are presented as paired tissue comparisons, mean ± S.E.M. 
n=6.
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Effect of Norcocaine on Norepinephrine Responses. The concentration- 
effect curves for norepinephrine in the presence and absence o f norcocaine 
(10 pM) are presented in Figure 10. Norcocaine significantly potentiated the 
maximum response to norepinephrine by 54%, p<0.05 . EC50 values and area 
under the concentration-effect curve values for norepinephrine alone and 
norepinephrine in the presence o f norcocaine were not significantly different, due 
to large variations among tissue responses.
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Figure 10. Effect of norcocaine (lOpM) on the vasoconstrictive response to 
norepinephrine. Data are presented as the mean ± S.E.M. of paired tissue 
comparisons, n=6, *< p 0.05.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Agonist Responses in the Presence o f Cocaethylene
41
Effect of Cocaethvlene on Serotonin Responses. The responses o f the 
isolated human umbilical artery to serotonin in the presence and absence of 
cocaethylene are presented in Figure 11. Cocaethylene did not potentiate the 
concentration-effect curve to serotonin significantly. An increase in maximum 
responses of 23% indicates increased sensitivity to serotonin of the tissue in the 
presence o f cocaethylene.
Figure 11. Effect of cocaethylene (10 pM) on the vasoconstrictive response to 
serotonin. Data are presented as the mean ± S.E.M. of paired tissue 
comparisons, n=7.
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Effect o f Cocaethylene on Norepinephrine Responses. The concentration- 
effect curves for norepinephrine alone and in the presence of cocaethylene are 
presented in Figure 12. Cocaethylene potentiated the maximum response to 
norepinephrine by 44%. The leftward shift of the concentration-effect curve 
indicates greater sensitivity of the tissue to norepinephrine in the presence of 
cocaethylene. There were no significant differences between concentration-effect 
curves despite the obvious effect of cocaethylene, this is probably due to large 
variations among tissue responses.
F igure 12. Effect of cocaethylene (10 |iM) on the vasoconstrictive response to 
norepinephrine. Data are presented as the mean ± S.E.M. of paired tissue 
comparisons, n=7.
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Comparison o f Potency Between Cocaine and Metabolites
Area under the concentration-effect curve values were determined for 
serotonin and norepinephrine in the presence or absence of cocaine and its 
metabolites. The differences in the concentration-effect curves between the 
presence or absence o f cocaine or its metabolites for each neurotransmitter were 
calculated and used to perform a multiple comparisons analysis of variance 
between effects o f cocaine and its metabolites. The mean values for the area under 
the concentration-effect curve differences for serotonin in the presence or absence 
of cocaine or metabolites are presented in Table 3. The mean values for area under 
the concentration-effect curve differences for norepinephrine in the presence and 
absence of cocaine or metabolites are presented in Table 4. The effect for 
serotonin with cocaine, norcocaine, or cocaethylene was significantly greater than 
that of serotonin with benzoylecgonine. The order of potency for cocaine and its 
metabolites based on the greatest to the least effect between the presence and 
absence of cocaine or metabolite in response to serotonin and norepinephrine is: 
cocaine>norcocaine>cocaethylene»»benzoylecgonine.
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TABLE 3.
Cummulative effects"- for serotonin in the 
presence or absence of cocaine or metabolites.
Serotonin / Cocaine Serotonin / 
Benzoylecgonine
Serotonin / 
Norcocaine
Serotonin / 
Cocaethylene
283.80 (109.49) -351.00* (139.35) 201.85 (103.18) 141.28 (89.62)
* p<0.05
+Data is the mean, % contraction (KC1 MAX)/ pM concentration, (S.E.M.) of 4-7 paired 
observations.
TABLE 4.
Cummulative effects* for norepinephrine in the presence of cocaine or metabolites.
Norepinephrine/
Cocaine
Norepinephrine/
Benzoylecgonine
Norepinephrine/
Norcocaine
Norepinephrine/
Cocaethylene
439.52 (167.26) 48.00 (38.42) 320.46 (156.28) 262.31(125.88)
+Data is the mean, % contraction (KC1 MAX)/ pM concentration, (S.E.M.) of 4-7 paired 
observations.
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Domination o f Alphat Receptor Presence
Additions of methoxamine, a potent alpha, agonist, were made to tissue 
bath preparations. The addition o f increasing concentrations o f methoxamine 
(0.01 - 10 pM) produced no effect on the human umbilical artery. There was no 
change from baseline tension over the entire concentration range.
Effect o f Ketanserin on Cocaine Potentiation o_f Serotonin Responses
The concentration-effect curves for serotonin alone, serotonin with cocaine, 
and serotonin with cocaine and ketanserin are presented in Figure 13. Calculated 
EC50's for each drug combination are given in Table 5. Cocaine potentiated the 
response to serotonin as shown by the leftward shift of the concentration-effect 
curve to serotonin in the presence o f lOpM cocaine. Ketanserin (0.03 pM) was 
able to attenuate the enhanced vasoconstriction produced by cocaine. Ketanserin 
significantly increased the EC50 for serotonin with cocaine, shifting the EC50 to 
the right 10-fold (p<0.05). The calculated pKB value (log [dose ratio - 1] = log 
[antagonist] - log KB) for serotonin with cocaine was 8.30. Ketanserin was also 
able to significantly depress the response to serotonin at 0.03 |iM and 0.1 jiM by 
87% and 102% respectively (p<0.05) in the presence of cocaine (lOpM).
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Figure 13. Effect of ketanserin (0.03 pM) on the potentiation of serotonin by 
cocaine (10 pM). Data are presented as the mean ± S.E.M. of paired tissue 
comparisons, n=5 , * p<_0.05.
TABLE 5.
EC50 values for serotonin alone, with cocaine and 
with cocaine and ketanserin.
Serotonin 0.049 ± .006 pM
Serotonin / Cocaine 0.022 ± .005 pM
Serotonin / Cocaine / 
Ketanserin
0.32 ± .09 pM *
Data is the mean ± the S.E.M.
* - Significantly different from serotonin with cocaine, p<0.05
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Effect of Ketanserin on Cocaine Potentiation ofNorepinephrine Responses
The concentration-effect curves for norepinephrine alone, norepinephrine 
with cocaine, and norepinephrine with cocaine and ketanserin are presented in 
Figure 14. EC 15 values, were calculated and used for comparison because this is 
the responses at which parallel shifts in the concentration-effect curves for 
norepinephrine can best be compared. The EC 15 values for each drug 
combination are given in Table 6. Cocaine was able to potentiate the 
concentration-effect curve to norepinephrine as shown by the 205-fold leftward 
shift of the EC 15 in the presence o f 10pM cocaine. The potentiation o f 
norepinephrine by cocaine was completely attenuated by ketanserin (0.03 fiM) in 
this tissue. Ketanserin produced a 205-fold rightward shift o f the EC 15 to 
norepinephrine in the presence of cocaine. The calculated pKB value for 
norepinephrine with cocaine was 9.17. Ketanserin significantly depressed the 
maximum response to norepinephrine by 54% at 1 pM (p<0.05) in the presence of 
lOpM cocaine.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
48
§*
O
*
o o
"O " NOREPINEPHRINE WITH COCAINE 
NOREPINEPHRINE *
NOREPINEPHRINE WITH 
COCAINE AND KETANSERIN
« 1 * 17 6^
[NOREPINEPHRINE] (M)
Figure 14. Effect of ketanserin (0.03 pM) on the potentiation of norepinephrine by 
cocaine (10 pM). Data are presented as the mean of paired tissue comparisons, n=5, 
*p<0.05.
TABLE 6.
EC 15 values for norepinephrine alone, with cocaine, and with cocaine and ketanserin.
Norepinephrine/Cocaine 0.79 ± 0.05 pM
Norepinephrine/Cocaine/
Ketanserin
3.6* ± 1.5 pM
Data is the mean (standard deviation).
* - Significantly different from norepinephrine with cocaine, p<0.05
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^H-Ketanserin Saturation
Umbilical arteries were homogenized and prepared as described in the 
Materials and Methods. The membrane fraction was assayed for serotonin^ and 
serotonin2c binding characteristics. The binding maximum (Bmax) and the 
dissociation constant (K J for 3H-Ketanserin was calculated using Graphpad 
PRISM nonlinear regression analysis. The binding characteristics of 3H- 
Ketanserin fit best to a one site binding equation as determined by the sequential 
F-test. Bmax was 14.610 nmol/mg, KD was 241.6 nM, and the non-specific binding 
was 112.204 nmol/mg. The saturation curve for 3H-Ketanserin is presented in 
Figure 15.
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Figure 15. 3H-ketanserin saturation binding characteristics. Data are 
presented as the mean ± S.E.M., n=6.
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Displacement of 3H-Ketanserin bv Mianserin
3H-ketanserin was competively displaced by mianserin, a serotonin2aib>&c 
antagonist. The KD for mianserin was 0.29 ± .083 jxM, the displacement curve fit 
best to the one-site competition equation according to the sequential F-test, F = 
5.746 and p = 0.01629. The displacement curve for mianserin presented in Figure 
16.
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Figure 16. Mianserin displacement of 3H-ketanserin (3 nM). Data are presented 
as the mean ± S.E.M., n=6.
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Serotonin Displacement o f 3H-Ketanserin
Serotonin competitively displaced 3H-ketanserin. The displacement curve 
for serotonin fit best to the two-site competition equation, F = 6.2 and p = 0.04 
with a Kd 2.8 ± 1.9 nM for one site and a KD 2.7 ±  0.72 pM for the second site. 
The displacement curve for serotonin is presented in Figure 17.
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Figure 17. Serotonin displacement of 3H-ketanserin (3 nM). Data are 
presented as the mean ± S.E.M., n=6.
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Tyramine Displacement of 3H-Ketanserin
Tyramine was able to displace 3H-ketanserin at two sites as determined by 
the sequential F-test, F = 21.56 and p = 0.011. The KD for one site was 7.88 ±  7.82 
nM and the KD for the second site was 36.24 ±  32.44 pM The displacement curve 
for tyramine is presented in Figure 18.
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Figure 18. Tyramine displacement of 3H-ketanserin (3 nM). Data 
are presented as the mean ± S.E.M., n=6.
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Norepinepinephrine Displacement of 3H-Ketanserin
Norepinephrine produced minimal displacement of 3H-ketanserin, only 4% 
of total binding was displaced (Figure 19). Even at a concentration of 10 pM 
norepinephrine were there was no significance difference from the control.
£ 75.
a
Control
Figure 19. Norepinephrine displacement of 3H-ketanserin (3 nM). 
Data are presented as the mean ± S.E.M., n=6.
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CHAPTER 4
DISCUSSION
The in vitro toxicity o f cocaine and its metabolites and the antidotal 
potential for ketanserin in human umbilical artery toxicity produced by cocaine 
were examined in this study. Cocaine abuse has been implicated in a number of 
perinatal complications presumably arising from the vasoconstrictive actions of 
cocaine such as placental abruption and preterm labor. Studies conducted in the 
isolated ovine (Dyer 1970) and guinea pig (Nair and Dyer 1974) umbilical arteries 
have provided evidence that cocaine may potentiate serotonin and norepinephrine 
constriction o f umbilical arteries. Several cocaine metabolites, benzoylecgonine, 
norcocaine, and cocaethylene seem to possess pharmacological activity similar to 
cocaine itself, in that all three produced vasoconstriction o f fetal cerebral porcine 
arterioles (Kurth et al. 1993). Tuncer et al. (1985) reported that ketanserin and 
mianserin antagonized serotonin induced contractions o f human umbilical artery 
strips, and ketanserin has been touted as a safer alternative to hydralazine in 
perinatal hypertension (Rossouw et al. 1995).
Innervation of the human umbilical artery was investigated using tyramine, 
an indirect acting sympathomimetic, in an isolated tissue model. Concentrations 
of tyramine were added to the baths to produce vasoconstriction which should be
54
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abolished by the addition of cocaine. The ability o f cocaine to produce enhanced 
contractile responses to serotonin and norepinephrine in the isolated umbilical 
artery ring model was analyzed. Cocaine metabolites, benzoylecgonine, 
norcocaine, and cocaethylene were also examined for their ability to enhance 
responses to serotonin and norepinephrine. The serotonin2 antagonist ketanserin 
was used to delineate the question of receptor types involved in cocaine 
potentiation o f vasoconstrictive responses. Membrane binding studies were 
conducted using 3H-ketanserin to determine the displacement characteristics of 
mianserin, serotonin, tyramine, and norepinephrine at serotonin2 receptors in the 
smooth muscle o f the umbilical artery.
Innervation o f the Isolated Human Umbilical Artery 
The innervation of the umbilical vasculature has been a topic of controversy 
for several decades. Even as recently as 1990 the conflict continued; no evidence 
of innervation in the umbilical vasculature was initially demonstrated using 
immunohistological and histochemical techniques (Fox and Khong 1990), yet in 
another study the presence of adrenergic and cholinergic nerve fibers were 
revealed in umbilical arteries at the fetal end o f the human umbilical cord using 
histochemical techniques (Kawano and Mori 1990). The possibility o f adrenergic
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innervation in human umbilical artery suggests a role for cocaine in potentiating 
vasoconstriction produced by norepinephrine and serotonin.
Tyramine is an indirect-acting sympathomimetic substance which produces 
a pressor response in other tissues by producing norepinephrine release from 
presynaptic nerve terminals (Figure 20). The vasoconstrictive effect of tyramine in 
other tissues is abolished or inhibited by cocaine's blockade o f the presynaptic 
uptake of tyramine.
PRESYNAPTIC TERMINAL
uptake-1 site V
POSTSYNAPTIC TERMINAL
alpha-1 receptor
^  vasoconstriction
vesicle
Figure 20. Diagrammatic representation of the pharmacological mechanism of 
tyramine. Tyramine displaces norepinephrine from presynaptic nerve terminals, 
norepinephrine binds to post-synaptic alpha, adrenoceptors to produce 
vasoconstriction.
norepinephrine V tyramine O
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Tyramine produced only a minimal response at a concentration of 10 pM which 
may be due to limited norepinephrine containing presynaptic nerve terminals and 
lower alpha! adrenoceptor density than would normally be present in arterial 
smooth muscle. The weak response of the umbilical artery to norepinephrine 
supports this concept. At a 100 pM tyramine concentration, there was a 
vasoconstrictive response, which was significantly greater in the presence of 
cocaine (lOpM). The potentiation by cocaine produced a vasoconstrictive 
response to tyramine that was similar in magnitude to the KC1 maximum. These 
results are similar to the findings of Gulati and Kelkar (1970); their study 
demonstrated a 20% potentiation of vasoconstrictive responses to tyramine in the 
isolated human umbilical cord perfusion model by cocaine. These results provide 
functional evidence that umbilical arteries are innervated and tyramine is 
producing its effects at an unidentified postsynaptic receptor. The paradoxical 
potentiation of tyramine-induced vasoconstriction by cocaine in umbilical arteries 
suggests that the effect o f cocaine to inhibit its uptake into the nerve terminal is 
exacerbating this direct effect. It is also possible that the endothelium-dependent 
mechanism proposed by Zhang and Hu (1998) for serotonin potentiaion by cocaine 
may be applicable to tyramine potentiation by cocaine as well.
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Cocaine Enhancement of Vasoconstrictive Responses 
to Norepinephrine and Serotonin 
Exposure o f the human umbilical artery to serotonin produced repeatable 
contractions that were significantly enhanced by cocaine. The concentration-effect 
curve for serotonin in the presence o f cocaine was shifted to the left indicating 
greater sensitivity o f the tissue to serotonin in the presence of cocaine (10 pM). A 
vasoconstrictive response to norepinephrine was produced at very high 
concentrations and there was a significant potentiation o f this response in the 
presence of cocaine. Cocaine also produced a leftward shift of the concentration- 
effect curve to norepinephrine indicating enhanced sensitivity of the tissue to 
norepinephrine in the presence of cocaine as well.
These results are analogous to the findings o f Nair and Dyer (1974), who 
observed cocaine potentiation of serotonin and norepinephrine contractions in 
guinea pig umbilical artery strips. Gulati and Kelkar (1970) noticed that 
norepinephrine but not serotonin effects were potentiated by cocaine in the 
umbilical cord perfusion model. Dyer (1970) as well as Zhang and Hu (1998) 
produced cocaine potentiation of serotonin contractions in isolated ovine umbilical 
arteries. Dyer (1970) concluded that cocaine potentiation was produced by 
inhibition of neuronal reuptake of serotonin based on significant decrease o f 3H- 
serotonin uptake. Dyer (1970) also noted that the addition o f desmethylimipramine
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along with cocaine did not produce an exacerbation o f this effect. Zhang and Hu 
(1998) attributed cocaine potentiation o f serotonin contractions to the presence o f 
endothelium. In their study, removal of the endothelium abolished the enhanced 
contractile effect of serotonin in the presence o f cocaine. It is unclear whether 
cocaine is primarily inhibiting the reuptake o f norepinephrine and serotonin into 
the presynaptic nerve terminal, limiting the major means of inactivation for these 
neurotransmitters and/or by preventing serotonin-stimulated release of endothelial- 
relaxing factor as proposed by Zhang and Hu (1998) in the ovine umbilical artery.
Kopin et al. (1984) estimated the mean synaptic concentration of 
norepinephrine to produce a 50 mm Hg increase in mean arterial pressure in pithed 
rats to be 7 nM. They demonstrated that treatment with desipramine produced a 3- 
fold increase in this concentration; this is within the concentration range of 
norepinephrine we used and observed a vasoconstrictive potentiation with cocaine. 
Like cocaine, desipramine blocks neuronal uptake and this effect at a synaptic 
junction in vivo supports the clinical relevance of the effect we observed in vitro 
with similar concentrations o f norepinephrine.
Bodelsson and Stjemquist (1995) did not observe a potentiation of 
norepinephrine in the presence of a 1 pM (0.3 pg/mL) concentration of cocaine, a 
therapeutic to subtoxic plasma concentration in humans (therapeutic range of 0.05-
0.31 pg/mL, Winek 1994; Ellenhom et al. 1997). Our cocaine concentration o f 10
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pM (3.0 pg/mL), is comparable to a toxic to potentially lethal plasma cocaine level 
in humans (toxic to lethal range o f 0.9-21 pg/mL, Winek 1994; Baselt and Cravey 
1995). This suggests that the degree o f significant constriction in the umbilical 
artery is dependent upon cocaine concentration and is produced by relatively 
higher plasma concentrations o f  cocaine which may occur with prolonged abuse or 
toxic dosage. This situation is possible and especially relevant in the umbilical 
artery since pregnancy decreases the metabolism of cocaine and increases the 
maternal half-life of cocaine and its metabolites (Neale and Parks 1973).
Plessinger and Woods (1990) found that progesterone is involved in producing 
greater cardiovascular sensitivity to cocaine. In their study they found that 
cardiovascular toxicity in non-pregnant ewes was increased when progesterone 
was administered intramuscularly. Progesterone also increases the sensitivity of 
contractile alpha adrenoreceptors. Since progesterone concentrations increase with 
gestation, if the effects of cocaine are potentiated by progesterone, then cocaine 
use by the mother in the later stages o f pregnancy would pose potentially greater 
risk for toxic vasoconstrictive effects.
Serotonin is a potent vasoconstrictor of umbilical arteries and cocaine has 
been shown to inhibit the neuronal reuptake of this substance in the brain (Ritz et 
al. 1990). We did produce a significant potentiation of the vasconstrictive 
response to serotonin in the isolated human umbilical artery, demonstrating that
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both norepinephrine and serotonin could be involved in the acute vascular toxicity 
of perinatal cocaine abuse. This information is particularly important considering 
that the vasconstrictive effects of norepinephrine are augmented by serotonin (Van 
Neuten et al. 1985). The simultaneous potentiation o f norepinephrine and 
serotonin by cocaine and augmentation of these effects by the neurotransmitters 
themselves could result in a toxic and potentially lethal pressor response o f the 
umbilical artery to the fetus.
Potentiation o f Norepinephrine and Serotonin Effects bv Cocaine Metabolites 
Cocaine metabolites shown to exhibit vasoconstrictive and hemodynamic 
effects similar to or exceeding those of cocaine were examined in this study for 
their ability to enhance the contractile responses to serotonin and norepinephrine in 
the isolated human umbilical artery. Benzoylecgonine, norcocaine, and 
cocaethylene were added to the preparation in the same manner described for 
cocaine, concentration-effect curves were constructed for serotonin and 
norepinephrine in the presence or absence of each metabolite. The effects of these 
metabolites were compared to cocaine by calculating the difference between area 
under the curve values for serotonin and norepinephrine with or without cocaine or 
metabolite; these differences were compared using a multiple comparisons 
analysis of variance and Fisher’s LSD.
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Benzoylecgonine (10 pM) decreased in the maximum response to serotonin 
in this study by as much as 36%. The human umbilical artery was less sensitive to 
serotonin in the presence o f benzoylecgonine as shown by the significant decrease 
in the area under the concentration-efFect curve. Benzoylecgonine did not produce 
significant effects on norepinephrine responses in this study. There was a leftward 
shift of the EC 15 in the concentration-effect curve for norepinephrine in the 
presence o f benzoylecgonine, but the maximum response remained unchanged. 
Benzoylecgonine does produce effects alone in vivo and in vitro. These effects 
include increased cerebral vascular resistance in fetal lambs (Covert et al. 1994) 
and vasoconstrictive effects on fetal pig cerebral arterioles (Kurth et al. 1993). An 
in vitro study conducted by Madden and Powers (1990) using isolated cat cerebral 
arteries also demonstrated vasoconstrictive effects produced by benzoylecgonine. 
Norepinephrine induced constriction of the fetal pig arterioles was not potentiated 
by benzoylecgonine in the study by Kurth et al. (1994). Consistent with the 
serotonin findings in the present study, Covert et al. (1994) did notice an increase 
in fetal carotid blood flow in response to benzoylecgonine (peak serum 
concentration 3.61 mg/ml) administration in one ewe.
Norcocaine produced a significant potentiation o f the maximum 
norepinephrine response and increased the sensitivity o f the tissue to 
norepinephrine. Consistent with results produced in fetal pig cerebral arterioles,
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norcocaine was able to significantly potentiate norepinephrine constriction of the 
vessels and produced a significant decrease in arteriolar diameter (Kurth et al. 
1994). No significant effects were observed for the response to serotonin in the 
presence o f norcocaine (10 (iM). There was an increase in the maximum response 
to serotonin, but this effect was not statistically significant due to variation in 
tissue responsiveness.
In this study cocaethylene did not produce significant increases in 
norepinephrine or serotonin vasoconstrictive responses of the human umbilical 
artery. Kurth et al. (1994) observed significant potentiation of norepinephrine 
induced constriction o f fetal pig cerebral arterioles by cocaethylene and the authors 
reported cocaethylene to be a more potent constrictor of these arterioles than 
cocaine itself. Although the maximum response to norepinephrine in the presence 
of cocaethylene (10 p.M) was increased almost as considerably as that of 
norepinephrine with cocaine in this study, variation among tissue responses may 
have masked the statistical significance of cocaethylene enhancement.
Calculations o f cummulative effects between serotonin concentration-effect 
curves before or after exposure of the tissues to cocaine or a metabolite revealed 
that effects of cocaine, norcocaine, and cocaethylene were similar. The effect of 
benzoylecgonine was significantly less than other metabolites due to decreased 
sensitivity o f the tissue to serotonin in the presence of this metabolite. For
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norepinephrine mediated contractions, calculated differences revealed that the 
effects of cocaine, norcocaine, benzoylecgonine and cocaethylene were not 
significantly different.
Effect o f Methoxamine in the Human Umbilical Artery 
The response to norepinephrine produced in this study was minimal, and 
methoxamine, a potent alpha, receptor agonist did not produce a vasoconstrictive 
response the human umbilical artery. This suggests that norepinephrine is 
producing its effect through receptors other than alpha, adrenoceptors. It is also 
unlikely that norepinephrine produces constriction o f the umbilical artery through 
stimulation of alpha2 adrenoceptors since Tuncer et al. (1985) were unable to 
produce contraction of human umbilical artery strips with clonidine, an alpha2 
selective agonist.
Ketanserin Attenuation of Cocaine Effects 
We found that cocaine potentiates the maximum response to serotonin by as 
much as 28%. This is indicative of a significant role for serotonin in the perinatal 
toxicity which is seen with cocaine abuse. Tuncer et al. (1985) demonstrated 
antagonism of serotonin concentration-effect curves by ketanserin and mianserin 
in the human umbilical artery. Although the pA2 values reported for these 
antagonists were lower than those reported in other tissues, the parallel rightward
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shifts in the concentration-effect curves indicate that ketanserin may be useful in 
pathological serotonin-mediated contractions of the umbilical artery.
In these experiments ketanserin was able to antagonize the response to 
serotonin in the presence of cocaine, indicating that serotonin2 receptors are 
involved in the vasoconstrictive response to serotonin potentiated by cocaine. 
Because serotonin is a very potent constrictor of umbilical arteries and cocaine 
potentiates this effect, ketanserin may be a useful agent in the treatment of acute 
perinatal cocaine toxicity which involves constriction o f placental, uterine, and 
umbilical vasculatures.
We have also found that cocaine is able to produce a potentiation of 
norepinephrine-mediated vasoconstriction. Cocaine does potentiate the maximum 
response to norepinephrine by 64% (as noted in this study), however 
norepinephrine is not a very potent constrictor of umbilical arteries alone 
(Bodelsson and Stjemquist 1995). Methoxamine had no vasoconstrictive effect on 
isolated human umbilical arteries in our preparation. This indicates that 
norepinephrine may not be acting through alpha, receptors in this tissue. Based on 
the responses to phenylephrine and the antagonism o f prazosin and rauwolscine at 
alpha-adrenoceptors, Bodelsson and Stjemquist (1995) concluded that 
norepinephrine was producing its effect through alpha, and alpha2 adrenoceptors.
In the same study, the authors noted that methysergide, a nonspecific serotonergic
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antagonist, antagonized the concentration-effect curve of oxymetazoline, an alpha2 
agonist. In this study we examined the concept that norepinephrine may be 
exerting its effects through serotonin2 receptors. We found that ketanserin 
antagonized the potentiation o f norepinephrine by cocaine. The concentration- 
effect curve to norepinephrine with cocaine was shifted 60-fold to the right in the 
presence o f ketanserin and cocaine, which was a complete attenuation of the 
potentiation produced by cocaine. This indicates that norepinephrine stimulation 
of serotonin2 receptors may be a significant component of the enhanced response 
to norepinephrine produced by cocaine.
We have demonstrated that the vasoconstrictive effects of both 
norepinephrine and serotonin are potentiated by cocaine. The toxic potential of 
this situation is magnified by the concept that simultaneous stimulation of alpha- 
adrenoceptors and serotonin receptors is not merely additive but results in 
potentiation (Van Nueten et al. 1985). Since ketanserin is able to antagonize 
cocaine potentiation o f the responses to both norepinephrine and serotonin in the 
umbilical artery, this suggests a clinical role for ketanserin in the treatment of 
acute perinatal cocaine toxicity situations.
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3H-Ketanserin Membrane Binding Studies 
In this study the binding characteristics o f 3H-ketanserin were determined in 
the membrane fraction o f homogenized human umbilical artery sections.
Umbilical artery membrane fractions were paired to the tissues used in the 
ketanserin attenuation contractile studies. Specific and saturable binding o f 3H- 
ketanserin was produced, the KD and Bmax values calculated from the results of this 
study were much higher than those reported by Hu and Zhang (1997) for 3H- 
ketanserin in the ovine uterine artery (KD 1.46 ±  .38 nM and Bmax 31.9 ± 5.9 ftnol / 
mg protein). Similar results were obtained by Jazayeri et al. (1989) in the rat 
aortic smooth muscle cell (KD 1.63 ±  1.3, Bmax 69 ± 22 finol / mg protein . 
Indicating a very dense serotonin2 receptor population in the human umbilical 
artery but lower affinity of ketanserin for the receptors.
The specific binding of the radioligand was also reversible and could be 
displaced by increasing concentrations of mianserin, serotonin and tyramine. 
Norepinephrine was not able to displace the radioligand even at 10 pM 
concentrations. Consistent with this result, Jazayeri et al. (1989) were unable to 
displace 3H-serotonin with adrenergic agents in rat aortic smooth muscle cells. 
Paradoxical to the observations o f the findings in the contractile studies, where 
tissues were sensitive to ketanserin attenuation o f cocaine potentiated 
norepinephrine contraction, norepinephrine was unable to displace 3H-ketanserin
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in the membrane binding studies. In the contractile studies, ketanserin with 
cocaine was unable to antagonize the concentration-effect curve for 
norepinephrine alone, consistent with the inability o f norepinephrine to displace 
3H-ketanserin.
The concentration-dependent displacement of 3H-ketanserin by tyramine is 
a novel finding. While tyramine is reported to produce direct vasoconstrictive 
effects in the umbilical artery (Gulati and Kelkar 1970) a receptor type for this 
effect has never been described. Tyramine concentration-displacement curves fit 
best to the two-site competition model indicating that tyramine binds at two 
serotonin2 subtypes with very low affinity. In the contractile studies, tyramine 
produced vasoconstriction at a concentration of about 10-100 p M , and the KD 
calculated for tyramine at the second site 36.2 pM is within this concentration.
This provides good evidence that tyramine is producing its contractile effects 
through this receptor site, a serotonin2 subtype .
Serotonin concentration-displacement curves also fit best to the two-site 
competition model indicating that serotonin binds at two serotonin2 receptor 
subtypes. The KD values for serotonin in this tssue (KD 2.8 and 2700 nM) were 
higher than those for serotonin in cultured rat aortic smooth muscle (KD 0.4 and 80 
nM) indicating lower affinity of serotonin for serotonin2 receptors in human 
umbilical arteries. Based on the contractile responses to serotonin in the present
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study, the functional site for serotonin has a KD o f 2.8 nM in human umbilical 
arteries.
Since norepinephrine (10 pM) did not displace 3H-ketanserin, the 
vasoconstrictive effects o f norepinephrine are probably not produced through 
serotonin2 receptors. This conflicts with the results of the ketanserin contractile 
studies because cocaine potentiation o f norepinephrine was attenuated by 
ketanserin. One explanation for this conflict might be that norepinphrine is 
producing its effects through another serotonin receptor subtype for which 
ketanserin has some affinity.
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SUMMARY AND CONCLUSIONS
1. Tyramine produced a vasoconstrictive effect that was potentiated by 
cocaine in the isolated human umbilical artery. Cocaine enhancement of 
tyramine effects indicates that neuronal uptake of tyramine is not necessary 
for its sympathomimetic effect.
2. Cocaine potentiation o f both serotonin and norepinephrine vasoconstrictive 
responses indicates that the role of the umbilical artery in the 
vasoconstrictive toxicity o f perinatal cocaine abuse is significant. The 
mechanism whereby cocaine produces its potentiating effects remains 
unclear.
3. Norcocaine potentiation of norepinephrine responses provides evidence that 
this cocaine metabolite may play a role in exacerbation o f the 
vasoconstrictive complications attributed to perinatal cocaine abuse. 
Calculated effects o f cocaine and its metabolites on norepinephrine induced 
vasoconstriction revealed no significant differences. This indicates that in
70
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addition to cocaine and norcocaine, cocaethylene and benzoylecgonine may 
contribute to umbilical artery toxicity.
4. Cocaine metabolites norcocaine and cocaethylene did not produce 
significant enhancement of the serotonin contractile response. Maximum 
responses to serotonin were decreased in the presence o f benzoylecgonine.
It is unclear why benzoylecgonine decreased the sensitivity of this tissue to 
serotonin.
5. Methoxamine did not produce vasoconstriction of the human umbilical 
artery. This indicates that norepinephrine effects are unlikely to be 
mediated through alpha, receptors in this tissue.
6. Ketanserin abolished the potentiation of serotonin and norepinephrine 
responses by cocaine. Based on the findings of these contractile studies, 
cocaine potentiation o f serotonin and norepinephrine responses is mediated 
through sertonin2 receptors.
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7. Binding characteristics o f 3H-ketanserin reveal a very high KD for ketanserin 
in this tissue. Serotonin displaced ketanserin with very low affinity for 
serotonin2 receptors. Since tyramine was able to displace 3H-ketanserin in 
the membrane binding studies and its action is not dependent on neuronal 
uptake, tyramine may produce this response through postsynaptic serotonin2 
receptors. Norepinephrine did not displace 3H-ketanserin from the 
membrane fraction in this assay.
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Effects o f Cocaine. Norcocaine. and Cocaethvlene on the Isolated Human 
Umbilical Artery and Vein and the Influence o f Progesterone 
Research to date indicates that infants delivered to cocaine or cocaine and ethanol 
abusing mothers have displayed increased incidence o f neurological complications 
as well as other congenital anomalies. Cocaine use during pregnancy has been 
known to cause deleterious effects on placental function (decreased blood flow and 
nutrient transport) and on the fetus (growth retardation, SIDS, and teratologic 
effects) (Bingol et al. 1987), as well as on the pregnancy itself (spontaneous 
abortion, abruptio placentae, and premature delivery) (Acker et al.1983). These 
complications have generally been attributed to the sympathomimetic and 
vasoconstrictive actions of cocaine and its metabolites (Covert et al. 1994). The 
primary pathophysiological action of cocaine and its other metabolites is related to 
the onset o f hypertension and tachycardia. The etiology is directly related to 
increases in circulating norepinephrine (NE), due to a block of the transport of NE 
back into nerve terminals (Furchgott et al. 1963). This results in increased 
stimulation of alpha-1 and alpha-2 receptors by NE which causes vasoconstriction 
(Bayorh et al. 1983).
Cocaine is extensively metabolized in the plasma and liver, and its 
metabolites are cleared from the plasma more slowly than cocaine itself (Jatlow
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1987); this includes cocaethylene (Jatlow et al. 1991), a toxic metabolite formed 
by the liver when cocaine and ethanol are used concomitantly (Boyer and Petersen, 
1991). Cocaethylene is purported to be more toxic than cocaine and exhibits a 
lower LD50 in mice (Hearn et al. 1991). In one experiment involving porcine fetal 
cerebral arteries, cocaethylene was able to vasoconstrict these vessels more 
efficaciously than cocaine. In the same study, norcocaine, (although a minor 
metabolite o f cocaine), was shown to constrict these vessels as efficaciously as 
cocaine itself (Kurth et al. 1993).
The toxicity o f cocaine and its metabolites is greater due to decreased 
activity of cytochrome P450 enzymes during pregnancy and under the influence of 
progesterone (Neale and Parks, 1973). Thus, progesterone increases enzymatic 
demethylations thereby increasing plasma concentrations of cocaine metabolites 
which have longer half-lives than cocaine and increases vascular reactivity to 
alpha-adrenergic receptor agonists. This suggests that pregnancy would increase 
cocaine sensitivity by increasing the formation of norcocaine and decreasing 
norcocaine metabolism. In one study, the cardiovascular toxicity to cocaine was 
shown to be increased in the presence o f progesterone in nonpregnant ewes 
(Plessinger and Woods et al. 1990).
Numerous studies which have been conducted in animal models and in 
humans indicate that cocaine and its metabolites are rapidly transferred across the
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placenta. Cocaine and its metabolites are transferred almost as rapidly as 
antipyrine, a substance which is used as a marker for placenta flow (Schenker et al. 
1993). Although the placenta does contain considerable amounts o f smooth 
endoplasmic reticulum and acetylcholinesterase as well as butyrylcholinesterase 
activity has been confirmed in human placenta (Koshakji et al. 1974), there has 
been no transplacental metabolism of cocaine observed to date.
The toxicology and teratology o f cocaine during pregnancy and in the 
fetus can in part be attributed to vasoconstriction of the placenta (Mahalik et al. 
1984). The vasoconstriction of the placental vasculature has been postulated to 
cause a decrease in uterine blood flow. Conversely, it has also been postulated that 
it is the vasoconstriction o f the uterine vasculature initially which results in the 
decrease in blood flow to the placenta (Morgan et al. 1991). Conclusive data has 
yet to be presented to describe the true nature of this relationship. This decrease in 
blood flow has been proven to be the result of NE mediated vasoconstriction. This 
has been shown experimentally by incorporating tropacocaine, an agent which 
does not inhibit the reuptake of NE into the nerve terminal. In cocaine-exposed 
animals, there was a decrease in the amount of radio-labelled sodium transferred to 
the embryos. However, in the tropacocaine-exposed animals the transfer of the 
isotope was not reduced significantly (Mahalik et al. 1980). In response to 
intravenous cocaine administered to the uterine vasculature o f the pregnant ewe
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(Woods et al. 1987 and Moore et al. 1986), and to the pregnant nonhuman primate 
(Morgan et al. 1991), a dose-dependent reduction of uterine blood flow has been 
observed. This results in increased blood pressure and restricts the transfer of 
essential nutrients and oxygen across the placenta.
There have been few studies conducted which attempt to delineate the 
contribution of umbilical vasculature constriction to the fetal pathogenicity 
observed in human epidemiological data and in the animal model as a result of the 
administration of cocaine and its metabolites. Zhang and Dyer (1991) were able to 
produce dose-dependent contractions o f the umbilical vein with NE, but did not 
observe this effect in the umbilical artery. They also observed that neither the 
EC50 nor the maximal contraction o f the umbilical vein to NE were affected by 
cocaine, in contrast, tissue responsiveness in the vein to serotonin was potentiated 
8.9 fold by cocaine. Serotonin (5-HT) seems to illicit stronger vasoconstrictive 
responsiveness than epinephrine (EPI) or NE (even at large concentrations) in 
umbilical arteries (Yoshikawa and Chiba, 1991). Thus it becomes very significant 
to investigate the effects of cocaine and its metabolites on this type of vasculature 
in the presence o f 5-HT, NE, EPI, and dopamine (DA).
Unlike cocaine which acts at both dopaminergic and serotoninergic 
reuptake sites (Ritz et al. 1990), cocaethylene acts preferentially to block reuptake 
at dopaminergic nerve terminals (Woodward et al. 1991). Therefore, the first
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objective of this study will be to evaluate the invovlement of cocaine, 
cocaethylene, and norcocaine in potentiating the vasoconstrictive responses o f the 
isolated umbilical artery and vein to NE, 5-HT, EPI, and DA. Another point of 
interest arises when it is considered that ethanol, a vasodilator, must be circulating 
in order for the formation o f the toxic metabolite cocaethylene. The effect of this 
compound on the vasoconstrictive effects of cocaine and its metabolites will also 
be evaluated in this model. Also, since it has been observed that the presence of 
progesterone increases the cardiovascular toxicity of cocaine, this effect will be 
evaluated in this model along with the toxic metabolites, norcocaine, and 
cocaethylene. If this toxicity is observed in this model, studies will then be 
conducted using Mifepristone (RU486), a progesterone antagonist, to determine if 
this effect can be blocked.
Materials and Methods
In order to determine the effect of cocaine, norcocaine (NC), and 
cocaethylene (CE) on the contractile activity of isolated human umbilical arteries 
and veins, umbilical artery and vein rings will be prepared for isometric tension 
recording and exposed to pharmacologically relevant concentrations of these 
agents by the method o f Saade, et al.1995. Briefly, umbilical cords will be 
collected after vaginal or cesarean delivery and immediately placed in cold Krebs- 
bicarbonate solution. Arteries and veins will be dissected and cut into rings about
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
88
4 mm in length. The rings will be mounted in organ baths containing Krebs- 
bicarbonate solution at 37°C on stirrups which will be calibrated for isometric 
tension. A gas mixture o f  95% oxygen and 5% carbon dioxide will be used to 
maintain tissue viability. Vascular ring tension will be equilibrated to about 2 
grams or optimal tension depending on the responsiveness o f the tissues. The 
rings will be contracted with KC1 to confirm tissue viability and responsiveness. 
The contractile response o f each ring to the specific neurotransmitter, either NE, 5- 
HT, EPI, or DA will be used as the reference to then be calculated as a percentage 
of its reference contraction. Each tissue will serve as its own control for 
comparison of cocaine, NC and CE effects. A minimum of four and a maximum of 
eight replicates will be done of each dose response curve pending response 
variation for statistical significance.
Experimental Protocol
In order to address all of the aforementioned aims, this project will be 
divided into four parts. The first experiment will be conducted to determine the 
concentration o f Cocaine, NC or CE at which the dose response curves (10_7M - 
10'5M) to the neurotransmitters NE, EPI, DA, and 5-HT produces the greatest shift 
in the EC50 to potentiate the response to these neurotransmitters. Tissues will be 
exposed to concentrations o f metabolites beginning at 10"7M  for at least 45 
minutes prior to administration o f the neurotransmitters.
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In order to answer the question o f possible attenuation of the 
vasoconstrictive response o f the tissue to Cocaine, NC and CE by ETOH, the 
second experiment will be performed to construct a dose response curve to ethanol 
(25, 50, 100, 200 and 300 mg/dL) in the presence or absence of each o f these 
drugs. The attenuation of the contractile response produced by ETOH will be 
expressed as a percentage o f the maximal contraction observed from each 
compound. These dose response curves will be constructed in the presence o f 
those doses of either cocaine, NC or CE which produced the greatest shift o f the 
EC50 in the dose response curve for each of the neurotransmitters.
The next set o f experiments will be conducted to determine what effect 
exogenously applied progesterone will have on cocaine, NC or CE induced 
vasoconstriction. A dose response curve will be constructed for progesterone at 
concentrations which are characteristic o f the luteal phase of the menstrual cycle 
(mean 43 nmol/L, range 6-79.5 nmol/L) and the three trimesters o f pregnancy: 7- 
13 weeks (mean 86 nmol/L, range 32.6-139.9 nmol/L), 14-37 weeks (mean 162 
nmol/L, range 62.0-262.4 nmol/L), and 30-42 weeks (mean 467 nmol/L, range 
206.7-728.2 nmol/L). This dose reponse curve will then be reconstructed in the 
presence of cocaine, NC and CE and 50% dilatory dose of ETOH for comparison 
to the initial curve to determine if  there is an interactive response o f progesterone 
with these substances.
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Mifepristone (RU486) will be used in the final set of experiments to 
determine if  the enhanced vasoconstriction o f cocaine, NC and CE mediated by 
progesterone can be blocked, if  this effect is observed for progesterone. The 
isolated arteries and veins will be pretreated with single competitively antagonistic 
doses o f Mifepristone, then exposed to the aforementioned doses o f progesterone 
alone and with addition of 50% contractile doses o f cocaine, NC and CE. The 
attenuation o f Mifepristone will be calculated as a percentage of the maximum 
tension produced in the presence o f progesterone for each compound.
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INFORMATION ABOUT: Effects of Cocaine, Norcocaine, and Cocaethylene on the 
Isolated Umbilical Artery and Vein, and the Influence of Progesterone. 
INVESTIGATORS: Kenneth E. Ferslew, PhD., Tessa L. Long, Peter J. Rice, PhD., and
Frederick R. Jelovsek, M.D.
CONSENT FORM
I understand that the purpose of this research project is to leam more about how 
the body works and changes in response in pregnancy, medicines, and disease. After 
delivery and detachment of the umbilical cord, we will examine the response of nerve 
chemicals in the blood vessels to drugs of abuse. Also, we will try to determine if 
hormones present during pregnancy will enhance the effects of these drugs on the blood 
vessels.
I understand that my involvement in the study will be my consent for the 
umbilical cord (after delivery) to be used in this project. The umbilical cord which would 
normally be discarded after birth will instead be taken to the laboratory for 
experimentation.
Approximately 50 umbilical cords will be used in this study at the Johnson City 
Medical Center Hospital and the E.T.S.U. Department of Pharmacology, Quillen College 
of Medicine.
All medical procedures are required as part of my treatment. I understand that 
there are no additional risks associated with this study.
I understand that there are no benefits to me as a participant in this study.
The purpose of the study is to leam more about how the body functions normally 
and under the influence of drugs. My participation may benefit others in the future.
There is no additional cost for participating in this study.
I understand that my participation is voluntary. I realize that refusal to participate 
will in no way jeopardize benefits or treatments to which I am otherwise entitled. I am 
free to withdraw at any time without penalty or loss of benefits to which I am entitled. I 
understand that I may withdraw by notifying Tessa L. Long at 439-6208 or Kenneth E. 
Ferslew, PhD. at 439-6274. If I have any questions about the study I may contact either of 
these people as well.
Any questions about my rights as a research subject can be addressed to the ETSU 
Institutional Review Board (423/439-6134). East Tennessee State University does not 
provide compensation for medical treatment other than emergency first aid for any injury 
which may occur as a result of your participation as a subject in this experiment, claims 
arising against ETSU or any of its agents or employees may be submitted to the 
Tennessee Claims Commission for disposition to the extent allowable as provided under 
TC Section 9-8-307. Additional information concerning this may be obtained from the 
Chairman of the Institutional Review Board (IRB), 439-6134.
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INFORMATION ABOUT: Effects of Cocaine, Norcocaine, and Cocaethylene on the 
Isolated Umbilical Artery and Vein, and the Influence of Progesterone. 
INVESTIGATORS: Kenneth E. Ferslew, PhD., Tessa L. Long, Peter J. Rice, PhD., and 
Frederick R. Jelovsek, M.D.
I understand that a copy of the results of this experiment will be deposited on file 
in the Department of Toxicology, West Side of Memorial Center W269 on the ETSU 
campus for a period of at least 10 years after completion of the research project I 
understand that results of this study may be published and/or presented at meetings. I 
understand that study records are accessible to: ETSU IRB, Department of Health and 
Human Services, and coinvestigators. I also understand that my medical records will be 
maintained in strictest confidence according to current legal requirements, and will not be 
revealed unless required by law, except as noted above.
By signing below, I certify that I have read or had this document read to me and I 
have been given a copy. I have been given the opportunity to ask questions and to 
discuss my participation with the investigator. I freely and voluntarily choose to 
participate in this research experiment.
Patient’s Signature Date
Witness’ Signature Date
Investigator’s Signature Date
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX C 
Modified Krebs-Henseleit Buffer
94
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
95
Modified Krebs-Henseleit Buffer
Reagents
Stock A (IPX Concentrate)
Molecular Wt. Mass (g)
Sodium Cholride 58.44 132.00
Potassium Chloride 74.56 7.083
Calcium Chloride* 2H20 147.07 7.412
Magnesium Sulfate *7H20 246.48 5.866
Dextrose 180.16 20.00
Dissolve in Deionized Water 2000ml 
Stock B (1QX Concentrate!
Potassium Hyd. Phosphate 136.09 3.212
Sodium Bicarbonate 84.01 42.00
Dissolve in Deionized Water 2000ml
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Procedure
1. For 2 liters o f buffer, add 200 ml of stock A and B to a volumetric flask and 
bring up to volume with deionized water.
2. Addition of deionized water (about 500 ml) between the mixing of stock 
aliquots prevents precipitation of calcium salts.
3. The buffer is aerated with 95%02/ 5% C 02 for about 30 min before use.
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Modified Krebs-Henseleit Buffer 65mM PotassiumReplacing Sodium
Reagents
Stock A (IPX Concentrated
Molecular Wt. Mass (g)
Sodium Chloride 58.44 15.741
Potassium Chloride 74.56 23.792
Calcium Chloride*2H20 147.07 1.853
Magnesium Sulfate«2H20 246.48 1.466
Dextrose 180.16 5.00
Dissolve in Deionized water 500ml
Stock B (10X Concentrate)
Potassium Hyd. Phosphate 136.09 3.212
Sodium Bicarbonate 84.01 42.00
Dissolve in Deionized water 2000ml
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Procedure
1. For 1 liter 65 mM K+ buffer, add 100 ml of stock A and B and bring up to 
volume with deionozed water.
2. Addition of deionized water ( about 500 ml) between addition o f stock 
aliquots prevents the precipitation of calcium salts.
3. The buffer is aerated with 95%02/ 5% C 02 for about 30 min before use.
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Bradford Protein Assay
Principle
The Bradford method is based on the shift in absorption maximum (from 
465 to 595 nm) which occurs when protein binds to the dye Coomassie Brilliant 
Blue G-250. This protein assay is very reproducible and rapid; there is little 
interference from cations such as sodium or potassium nor from carbohydrates. 
Interfering color can be produced by large amounts of detergents.
Materials
Microtiter plates
Equipment
Spectra Max 340 Microplate Spectrophotometer 
(Molecular Devices, Sunnyvale, CA)
Reagent
Bio-Rad Protein Assay Dye Reagent Concentrate 
Bovine Serum Albumin (BSA) (1 mg/ml)
Procedure
1. Prepare lOOpl BSA standards containing 0, 0.1, 0.25, 0.5, 1.0,2.5, 5.0, 
10.0,25.0, 50.0, 100.0 pg. Use lOOpl sample o f unknown concentration 
(0.25-10 pg) protein.
2. Add 150 pi of diluted (1 part Reagent plus 2 parts water) Bio-Rad Dye and 
mix well. The reaction is complete within 2 min and is stable for 1 hour.
3. Read absorbance at 595 nm against a control with zero protein. 
Calculations
A standard curve is constructed using bovine serum albumin and used to 
convert absorbance at 595 nm to an equivalent protein concentration.
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Figure 21. Standard curve for Bradford protein assay. Data are 
represented by the mean of 4 replicates.
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